Cargando…

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

Detalles Bibliográficos
Autor principal:	Gao, Xiaoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382680/ https://www.ncbi.nlm.nih.gov/pubmed/37520127 http://dx.doi.org/10.3389/fnagi.2023.1247256

Ejemplares similares

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Editorial: Systemic implications of Alzheimer's disease
por: Cortes, Constanza J., et al.
Publicado: (2023)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Editorial: Improving memory deficits in Alzheimer's disease
por: Wang, Fushun, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias
por: Ibáñez, Agustín, et al.
Publicado: (2022)

Editorial: Insights in Alzheimer's disease and related dementias: 2022
por: Ibáñez, Agustín, et al.
Publicado: (2023)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Editorial: Methods and applications in Alzheimer's disease and related dementias
por: Yogi, Alvaro, et al.
Publicado: (2022)

Editorial: Insights into Parkinson's disease and aging related movement disorders
por: Petersen, Robert B., et al.
Publicado: (2023)

Editorial: Translational Advances in Alzheimer's, Parkinson's, and Other Neurodegenerative Dementias
por: Jiang, Jiehui, et al.
Publicado: (2022)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders
por: Uchida, Yuto, et al.
Publicado: (2023)

Editorial: New technologies for detection, monitoring and treatment of Parkinson's disease, volume II
por: Mirian, Maryam S., et al.
Publicado: (2023)

Editorial: Expert opinions on the relationship between microglia, glia, and Alzheimer's disease: 2022
por: Gomez-Arboledas, Angela, et al.
Publicado: (2023)

Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology
por: Bubu, Omonigho M., et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II
por: Ma, Tao, et al.
Publicado: (2023)

Editorial: Infection, inflammation, and neurodegeneration: A critical path to Alzheimer's disease, Volume II
por: Mancuso, Roberta, et al.
Publicado: (2022)

Editorial: Advancing the treatment landscape in Parkinson's disease using sensor technology and data-driven modeling
por: Ramdhani, Ritesh A., et al.
Publicado: (2022)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
por: Chen, Daoyuan, et al.
Publicado: (2023)

Alzheimer’s disease: an axonal injury disease?
por: Dan, Liang, et al.
Publicado: (2023)

Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias
por: Giménez-Llort, Lydia
Publicado: (2023)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Editorial: Mitochondrial and lysosomal dysfunction in neurodegenerative diseases: Molecular mechanisms and therapeutic strategies
por: Xiang, Chen, et al.
Publicado: (2022)

The Association of Pre-existing Diagnoses of Alzheimer’s Disease and Parkinson’s Disease and Coronavirus Disease 2019 Infection, Severity and Mortality: Results From the Korean National Health Insurance Database
por: Kim, Ji Hee, et al.
Publicado: (2022)

White matter hyperintensities burden in the frontal regions is positively correlated to the freezing of gait in Parkinson’s disease
por: Zou, Xiaoya, et al.
Publicado: (2023)

The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
por: Mari, Zoltan, et al.
Publicado: (2022)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

The Occurrence of Alzheimer’s Disease and Parkinson’s Disease in Individuals With Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Screening Database in Korea
por: Kwon, Mi Jung, et al.
Publicado: (2021)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

Editorial: New developments in understanding brain and cerebromicrovascular aging: Toward prevention of vascular cognitive impairment and Alzheimer's disease
por: Sanford, Madison, et al.
Publicado: (2022)

Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease
por: Nizari, Shereen, et al.
Publicado: (2022)

Tau kinetics in Alzheimer's disease
por: Hier, Daniel B., et al.
Publicado: (2022)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83tp9p72kh40eo83ebldejdkcn